Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06253962

Carotid Atherosclerosis in Predicting Coronary Artery Disease

Carotid plaque burden and composition features, particularly lipid necrotic core, are significantly associated with severity of CAD stenosis. This study aims to explore the relationship between various phenotypic patterns of carotid atherosclerosis with the prevalence, phenotype, and severity of coronary atherosclerosis. The patients with chest tightness or chest pain will receive carotid artery ultrasonography before coronary angiography so as to explore the relationship between them.

Recruiting

Interested in participating?

Request Info

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients receive carotid ultrasound and coronary angiography

Exclusion criteria

  • None

Treatment and study plan

coronary agiongraphy

Other

severity of coronary atherosclerosis

Primary outcomes

  1. MACE

    Time frame: two years after angiography

    acute myocardial infarction; heart failure; cardiac death; revascularization

Study contacts

Contact information is provided by the study sponsor or research team.

Danbo Lu, PhD

CONTACT

[email protected]

+86 021 64041990

Sponsors and collaborators

Lead sponsor

Shanghai Zhongshan Hospital

Other

Registry information

Acronym: CACA

Important dates

Study start
2024
Primary completion
2026
Study completion
2028
First posted
Feb 12, 2024
Registry last updated
Feb 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.